About us
Kaleb Mabo
Ceo & co-founder
Kaleb Mabo, proud grandson of Torres Strait Islander activist Eddie Koiki Mabo, continues his grandfather’s legacy of justice, cultural pride, and reconciliation. Eddie Mabo’s landmark case overturned terra nullius and secured native title recognition for Aboriginal and Torres Strait Islander peoples.
Through the Baizam Le-Mabo Legacy (BLML), Kaleb advances Koiki’s vision of cultural identity and unity. BLML promotes knowledge sharing, inclusivity, and reconciliation by celebrating the richness and diversity of Indigenous cultures across Australia, fostering mutual understanding and healing.
A former Royal Australian Navy sailor, Kaleb is pursuing a Bachelor of Arts in Anthropology and Archaeology at James Cook University, recognising anthropology’s power to connect Indigenous and non-Indigenous worldviews through evidence-based respect and dialogue.
Kaleb has led community projects including Mabo Day 2022 – the Dr Koiki Mabo Project, restoring his grandfather’s traditional home on Mer Island with the National Native Title Council. Currently leading community contribution strategies for a major resource company in Western Australia, he drives projects improving socio-economic outcomes across the Pilbara.
Dr Mark Wenitong
director & co-founder
Dr Mark Wenitong is one of Australia’s first Indigenous medical doctors and a founding member and past president of the Australian Indigenous Doctors’ Association (AIDA). He currently serves as Chair of the Queensland Health Statewide Aboriginal and Torres Strait Islander Clinical Network, National Mental Health Commissioner, and Strategic Advisor in Research Knowledge Translation for the Lowitja Institute, Australia’s national Aboriginal and Torres Strait Islander health research organisation.
Across a distinguished career, Dr Wenitong has held senior roles including Senior Medical Officer at Apunipima Cape York Health Council (ACCHO) for 11 years and has served on national committees such as the Federal Aboriginal and Torres Strait Islander COVID-19 Taskforce, National First Nations Genomics Committee, and the National Health Strategy Implementation Group.
He also serves on boards including Miwatj ACCHS (East Arnhem Land) and CEQ Remote Stores (FNQ and Torres Strait) and has previously served with AIATSIS and the Australian Institute for Tropical Health and Medicine.
Trained at the CDC (Atlanta), Johns Hopkins School of Public Health, and Harvard Medical School, Dr Wenitong’s focus is on preventing chronic disease and translating evidence into equitable, culturally safe primary healthcare policy and practice.
Troy Stewart
Director & Co-founder
Troy Stewart brings more than 26 years of senior management experience across Australia’s corporate, community, and government sectors, with a career shaped by innovation, public health leadership, and a strong commitment to Indigenous health outcomes. With deep experience in bespoke manufacturing he specialises in adapting advanced technologies to meet Australia’s local needs.
Troy joined the Prime Minister’s inaugural Austrade Delegation to China in 2016, building enduring partnerships with government and industry that continue to support Australia’s diagnostic resilience. He played a key role in Australia’s first Rapid Antigen Testing pilot at the Sydney Opera House helping pave the way for national adoption and later facilitated Austrade and DISER’s visit to appraise Hi tech advanced UK manufacturing facilities.
Troy also led Australia’s first drink-spiking pilot in Albury, demonstrating real-time forensic detection of ketamine, GHB, and benzodiazepines, contributing to criminal convictions. He remains committed to culturally safe, accessible diagnostic solutions for remote and Indigenous communities.
Dr Tim Boyle
PRINCIPAL strategic advisor & co-founder
Dr Tim Boyle is a globally recognised leader in research translation, intellectual property commercialisation, and innovation management, with more than two decades of experience connecting research with industry. Renowned for transforming ideas into impact, he has a proven record in technology licensing, collaboration, and venture creation across diverse sectors in Australia and internationally.
Before joining ARCS Australia, Tim was Director of Innovation & Commercialisation at ANSTO, where he founded and led the award-winning nandin Innovation Centre Australia’s largest community of science-based start-ups. He also oversaw business development, licensing, and technology transfer, establishing partnerships that strengthened Australia’s innovation ecosystem.
Tim’s governance and advisory roles span the pharmaceutical, health, and technology sectors, where he has shaped national policy and guided high-value collaborations. His leadership focuses on building sustainable frameworks that deliver measurable commercial, social, and health outcomes and holds academic and international appointments as Adjunct Professor at Swinburne University of Technology and Global Expert Faculty member at Singularity University, mentoring future innovators worldwide.
Before joining ARCS Australia, Tim was Director of Innovation & Commercialisation at ANSTO, where he founded and led the award-winning nandin Innovation Centre Australia’s largest community of science-based start-ups. He also oversaw business development, licensing, and technology transfer, establishing partnerships that strengthened Australia’s innovation ecosystem.
Tim’s governance and advisory roles span the pharmaceutical, health, and technology sectors, where he has shaped national policy and guided high-value collaborations. His leadership focuses on building sustainable frameworks that deliver measurable commercial, social, and health outcomes and holds academic and international appointments as Adjunct Professor at Swinburne University of Technology and Global Expert Faculty member at Singularity University, mentoring future innovators worldwide.